Univessel® SU 10 L Early Access Program
Be Among the First to Experience the Univessel® SU 10 L
The newest member of the Sartorius bioreactor portfolio is here. The Univessel® SU 10 L is a single-use, stirred-tank bioreactor designed to streamline process development and scale-up mammalian cell culture applications. Now, through our exclusive Early Access Program, you can gain priority access before the full market launch.
Why Join the Early Access Program?
- Pre-production (“Zero-series”) vessels for research and development.
- Direct engagement with our application specialists for tailored process evaluation.
- Access to exclusive technical resources, including datasheets and application data.
Why Univessel® SU 10 L?
Irradiated, ready-to-use vessels minimize setup time and cross-contamination risks.
Designed for seamless process transfer across Ambr®, Univessel®, and Biostat® STR.
Choose from Essential, Perfusion, or Cell Therapy to match your process needs.
Essential – Standard stirred-tank bioreactor with optimized mixing and gas exchange.
Perfusion – Built-in perfusion-ready capabilities for intensified bioprocessing.
Cell Therapy – Tailored for stem cell and cell therapy applications.
Univessel® SU 10 L: A Closer Look
Explore the Univessel® SU 10L – Designed for Efficiency & Scale
Engineered for precision and scalability, the Univessel® SU 10 L combines cutting-edge bioreactor technology with a user-friendly design. Explore its key features by interacting with the hotspots below.
Interested in getting ahead with the Univessel® SU 10L?
Register your interest today to receive technical datasheets, application data showcasing CHO Fed-Batch & N-1 Perfusion scalability across Ambr® 250, Univessel® SU 10L, and STR® 50—along with MSC microcarrier cell culture data and upcoming insights on viral vector and CAR-T—and a personalized consultation with your local Application Specialist.